Breast cancer follow-up in the adjuvant setting

Current Oncology Reports

Volumn 10, Issue 1, 2008, Pages 38-46

  Khatcheressian, James ^a   Swainey, Craig ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 27-29 ANTIGEN; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; TAMOXIFEN; TAXANE DERIVATIVE; TUMOR MARKER;

ADJUVANT THERAPY; BONE SCINTISCANNING; BREAST CANCER; BREAST SELF EXAMINATION; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CANCER SURVIVOR; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GENETIC COUNSELING; HIGH RISK PATIENT; HOT FLUSH; HUMAN; LABORATORY TEST; LOW FAT DIET; MAMMOGRAPHY; NEUROPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SOCIAL SUPPORT;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RISK REDUCTION BEHAVIOR; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 38149030008     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0007-x     Document Type: Review

References (57)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106-130.
2. Giordano SH, Buzdar AU, Smith TL, et al.: Is breast cancer survival improving? Cancer 2004, 100:44-52.
3. Olivotto IA, Baidik CD, Ravdin PM, et al.: Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005, 23:2716-2725.
4. Paik S, Tang G, Shak S, et al.: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24:3726-3734.
5. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol 1996, 14:671-679.
6. Khatcheressian JL, Wolff AC, Smith TJ, et al.; American Society of Clinical Oncology: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006, 24:5091-5097.
7. Grunfeld E, Dhesy-Thind S, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005, 172:1319-1320.
8. The NCCN Breast Cancer Clinical Practice Guidelines in Oncology (Version 2.2007). 2007 National Comprehensive Cancer Network, Inc. http://www.nccn.org/professionals/physician_gels/PDF/breast.pdf. Accessed July 16, 2007.
9. Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology. J Clin Oncol 1997, 15:2149-2156.
10. Smith TJ, Davidson NE, Schapira DV, et al.: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999, 17:1080-1082.
11. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 1994, 271:1587-1592.
12. Rosselli Del Turco M, Palli D, Cariddi A, et al.: Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial-National Research Council Project on Breast Cancer Follow-Up. JAMA 1994, 271:1593-1597.
13. Rojas MP, Telaro E, Russo A, et al.: Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005, (1)CD001768.
14. Palli D, Russo A, Saieva C, et al.: Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 1999, 281:1586.
15. Holli K, Saaristo R, Isola J, et al.: Effect of radiotherapy on the interpretation of routine follow-up mammography after conservative breast surgery: a randomized study. Br J Cancer 1998, 78:542-545.
16. Thomas DB, Gao DL, Ray RM, et al.: Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002, 94:1445-1457.
17. de Bock GH, Bonnema J, van der Hage J, et al: Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: A meta-analysis and systematic review. J Clin Oncol 2004, 22:4010-4018.
18. Mille D, Roy T, Carrere MO, et al.: Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center. J Clin Oncol 2000, 18:1718-1724.
19. Grunfeld E, Mant D, Yudkin P, et al.: Routine follow up of breast cancer in primary care: randomised trial. BMJ 1996, 313:665-669.
20. Loprinzi CL, Hayes D, Smith T: Doc, shouldn't we be getting some tests? J Clin Oncol 2000, 18:2345-2348.
21. Keating NL, Landrum MB, Guadagnoli E, et al.: Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 2007, 25:1074-1081.
22. Grunfeld E, Levine MN, Julian JA, et al.: Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006, 24:848-855.
23. Montgomery DA, Krupa K, Cooke TG: Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer 2007, 96:1625-1632.
24. Gulliford T, Opomu M, Wilson E, et al.: Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ 1997, 314:174-177.
25. Bornhak S, Heidemann E, Herschlein HJ, et al.: Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicenter study. Onkologie 2007, 30:443-449.
26. Kuhl CK, Schrading S, Leutner CC: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469-8476.
27. Leach MO, Boggis CR, Dixon AK: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005, 365:1769-1778.
28. Lehman CD, Gatsonis C, Kuhl CK, et al.: MRI evaluation of the contralateraI breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
29. Saslow D, Boetes C, Burke W, et al.; American Cancer Society Breast Cancer Advisory Group: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89.
30. Vranjesevic D, Filmont JE, Meta J, et al.: Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med 2002, 43:325-329.
31. Kamel EM, Wyss MT, Fehr MK, et al.: [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer. J Cancer Res Clin Oncol 2003, 129:147-153.
32. Isasi CR, Moadel RM, Blaufox MD: A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 2005, 90:105-112.
33. Drotman MB, Machnicki SC, Schwartz LH, et al.: Breast cancer: assessing the use of routine pelvic CT in patient evaluation. AJR Am J Roentgenol 2001, 176:1433-1436.
34. Hurria A, Leung D, Trainor K, et al.: Screening chest imaging studies are not effective in the follow-up of breast cancer patients. J Oncol Manag 2003, 12:13-15.
35. Gion M, Mione R, Leon AE, et al.: CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases. Eur J Cancer 2001, 37:355-363.
36. Chan DW, Beveridge RA, Muss H, et al. Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. J Clin Oncol 1997, 115:2322-2328.
37. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717.
38. Institute of Medicine and National Research Council, Committee on Cancer Survivorship - Improving Care and Quality of Life, National Cancer Policy Board: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academie4 Press; 2005.
39. Haggstrom DA, Quale C, Smith-Bindman R: Differences in the quality of breast cancer care among vulnerable populations. Cancer 2005, 104:2347-2358.
40. Keating NL, Landrum MB, Guadagnoli E, et al.: Factors related to underuse of surveillance mammography among beast cancer survivors. J Clin Oncol 2006, 24:85-94.
41. Mallinger JB, Griggs JJ, Shields CG: Patient-centered care and breast cancer survivors' satisfaction with information. Patient Educ Couns 2005, 57:342-349.
42. Salminen E, Vire J, Poussa T, Knifsund S: Unmet needs in information flow between breap cancer patients, their spouses, and physicians. Support Care Cancer 2004, 12:663-668.
43. Hodgkinson K, Butow P, Hunt GE, et al.: Breast cancer survivors' supportive care needs 2-10 years after diagnosis. Support Care Cancer 2007, 15:515-523.
44. Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A: How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 1998, 83:1640-1651.
45. Shimozuma K, Ohashi Y, Takeuchi A, et al.: Assessment and quantification of taxane-induced neurotoxicity in a phase III randomized trial of breast cancer (AC followed by PAC/DOC vs. PAC/DOC alone): N-SAS BC 02 [ASCO abstract 8523]. J Clin Oncol 2006, 24:(Suppl):abstract 8523.
46. Gupta P, Sturdee DW, Palin SL, et al.: Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006, 9:49-58.
47. Tham YL, Sexton K, Weiss HL, et al.: The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. J Support Oncol 2006, 4:295-298, 304.
48. Kissane DW, Grabsch B, Love A, et al.: Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry 2004, 38:320-326.
49. Passik SD, Dugan W, McDonald MV, et al.: Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998, 16:1594-1600.
50. Detmar SB, Muller MJ, Wever LD, et al.: The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA 2001, 285:1351-1357.
51. Janz NK, Wren PA, Copeland LA, et al.: Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol 2004, 22:3091-3098.
52. Bruera E, Willey JS, Palmer JL, et al.: Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer 2002, 94:2076-2080.
53. Holmes MD, Chen WY, Feskanich D, et al.: Physical activity and survival after breast cancer diagnosis. JAMA 2005, 293:2479-2486.
54. Chlebowski RT, Blackburn GL, Thomson CA, et al.: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006, 98:1767-1776.
55. Pierce JP, Stefanick ML, Flatt SW, et al.: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007, 25:2345-2351.
56. Hortobagyi GN; American Society of Clinical Oncology: A shortage of oncologists? The American Society of Clinical Oncology Workforce study. J Clin Oncol 2007, 25:1468-1469.
57. Doubeni CA, Field TS, Ulcickas Yood M, et al.: Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 2006, 106:2482-2488.